This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Varian Medical Systems Showcasing New Knowledge-Based Treatment Planning Software For Radiation Oncology

ATLANTA, Sept. 23, 2013 /PRNewswire/ -- ASTRO Booth #1115 -- Varian Medical Systems (NYSE: VAR) is showcasing a new knowledge-based software tool designed to expedite creation of complex intensity-modulated radiotherapy (IMRT) treatment plans at the 54 th annual meeting of the American Society for Radiation Oncology (ASTRO) this week. 

Varian's new RapidPlan™ software* will provide clinicians with standard of care models to use as a baseline for developing new IMRT treatment plans for their patients.  IMRT is a type of radiotherapy that focuses precisely on the tumor while minimizing exposure of surrounding healthy tissues.

"RapidPlan will improve the quality and efficiency of treatment planning, much like our RapidArc technology enhanced treatment delivery," says Chris Toth, vice president of marketing for Varian's Oncology Systems business.  "The RapidPlan software will change treatment planning by providing users with access to a knowledge base with standard-of-care models developed by leading practitioners.  The goal is to help increase treatment plan quality and reduce variability without adding time to the planning process."

RapidPlan is a comprehensive tool within Varian's Eclipse™ treatment planning system that may be used to plan virtually every type of external beam radiotherapy, including intensity-modulated radiotherapy (IMRT), image-guided radiotherapy (IGRT), RapidArc® radiotherapy, stereotactic body radiotherapy (SBRT), and stereotactic ablative radiotherapy (SABR).   It is seamlessly integrated with Varian's Eclipse™ treatment planning software.

"RapidPlan is designed to be a 'learning system,'" says Corey Zankowski, vice president of product management.  "Clinicians can select their 'best' treatment plans to include in a training set that can be used to create new and improved practice models in the future.  In doing so, sites can customize RapidPlan to reflect their own practices.  The models can also be shared among colleagues within a care network to create a practice standard.  Eventually, as local knowledge bases expand and improve, organizations will be able to share best practices between institutions."

"RapidPlan helps automate an important part of the treatment planning process, in much the same way as our Smart Segmentation™ knowledge-based tool, introduced in 2011, which automates contouring of organs within diagnostic images," says Toth.   "Both tools are designed to allow clinicians to access an extensive body of clinical experience while expediting cumbersome, time-consuming processes."

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $94.19 -1.04%
FB $118.06 0.54%
GOOG $695.70 0.48%
TSLA $222.56 -4.20%
YHOO $36.00 -0.03%


Chart of I:DJI
DOW 17,651.26 -99.65 -0.56%
S&P 500 2,051.12 -12.25 -0.59%
NASDAQ 4,725.6390 -37.5850 -0.79%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs